Close
Nordic 9Nordic 9

Merozyne Therapeutics (private company)

Sweden merozyne.com
See something wrong or missing? Let us know
Offices:Lund
Industry:BiotechHealth services
Business model:B2B

Merozyne Therapeutics has been established to develop a treatment for MDC1A, a new drug for a rare incurable muscle disease - congenital muscular dystrophy.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 690k

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Merozyne Therapeutics

Name Criteria
Sweden VOC Diagnostics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Valink Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Aquilón CyL
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Switzerland Bionomous
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Celluminova
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Cornea Project
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Ikan Biotech
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden In Singulo Solutions AB
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Novai
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden PeptiSystems
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Top